ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK)

Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) (SHEZF)

0,4696
0,00
(0,00%)
Geschlossen 11 Juli 10:00PM

Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) (SHEZF) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
0,4696
( - )
Gebot
0,4989
Fragen
0,5789
Volumen
-
Durchschnittliches Volumen (3 Mio.)
US$ 4.736.031
Finanzvolumen
-
0,00 Tagesbereich 0,00
0,4696 52-Wochen-Bereich 0,4696
Marktkapitalisierung
Unternehmenswert
12,296B
Handelsende
0,4696
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
VWAP
-
Erlöse (LTM)
5,42B
Nettogewinn (LTM)
380,47M
Ausgegebene Aktien
1.467.296.204
Streubesitz (%)
28,14%
Institutioneller Besitz (%)
3,41%
Dividendenrendite (LTM)
0,15 (1,51%)
Kurs-Gewinn-Verhältnis
36,13
Kurs-Umsatz-Verhältnis (KUV)
2,31
Gewinn pro Aktie (EPS)
0,26
Beta
0,31

Über Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK)

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. provides pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. It operates in four segments: Pharmaceutical preparations, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing O... Shenzhen Hepalink Pharmaceutical Group Co., Ltd. provides pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. It operates in four segments: Pharmaceutical preparations, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization (CDMO), and Others. The company offers pharmaceutical preparations products, such as enoxaparin sodium injection; API products, including heparin and enoxaparin sodium APIs. It also provides molecule biologics CDMO services, which include research and development, manufacturing, quality management, and program management services, as well as technical support services. In addition, the company develops apabetalone (RVX-208), a BET bromodomain protein inhibitor in Phase 3 trial to reduce major adverse cardiovascular events, as well as in Phase 2 trial for diabetic nephropathy and fatty disease; oregovomab, a monoclonal antibody in Phase 3 trial for ovarian cancer, as well as in Phase 2 for pancreatic cancer; tosatoxumab (AR-301), a fully human IgG1 monoclonal antibody in Phase 3 trial for ventilator-associated pneumonia; and H1710, a heparanase inhibitor preparation for solid tumors. Further, it engages in property management, investment management and consulting, biopharmaceutical technology development and consulting, and equity and venture investment activities; provision of services on pharmaceutical related activities; and trading of medical and biopharmaceutical products. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. was formerly known as Shenzhen Hepalink Pharmaceutical Co.,Ltd. and changed its name to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in February 2017. The company was founded in 1998 and is headquartered in Shenzhen, the People’s Republic of China. Mehr anzeigen

Sektor
-
Branche
-
Hauptsitz
Shenzhen, China
Gegründet
1998
Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) is listed in the sector of the OTC Markets with ticker SHEZF. The last closing price for Shenzhen Hepalink Pharma... (PK) was US$0,47. Over the last year, Shenzhen Hepalink Pharma... (PK) shares have traded in a share price range of US$ 0,4696 to US$ 0,4696.

Shenzhen Hepalink Pharma... (PK) currently has 1.467.296.204 shares in issue. The market capitalisation of Shenzhen Hepalink Pharma... (PK) is US$689,04 million. Shenzhen Hepalink Pharma... (PK) has a price to earnings ratio (PE ratio) of 36.13.

SHEZF Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
12000.46960.46960.469600CS
26000.46960.46960.469600CS
52000.46960.46960.469600CS
156-0.251-34.83208437410.72060.72060.4696130.4696CS
260-0.6956-59.69790593891.16521.50.46963461.09111582CS

SHEZF - Frequently Asked Questions (FAQ)

What is the current Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) share price?
The current share price of Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) is US$ 0,4696
How many Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) shares are in issue?
Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) has 1.467.296.204 shares in issue
What is the market cap of Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK)?
The market capitalisation of Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) is USD 689,04M
What is the 1 year trading range for Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) share price?
Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) has traded in the range of US$ 0,4696 to US$ 0,4696 during the past year
What is the PE ratio of Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK)?
The price to earnings ratio of Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) is 36,13
What is the cash to sales ratio of Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK)?
The cash to sales ratio of Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) is 2,31
What is the registered address of Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK)?
The registered address for Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) is No. 21 Langshan Road, Shenzhen, Guangdong Province, 518057
What is the Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) website address?
The website address for Shenzhen Hepalink Pharmaceutical Group Company Ltd (PK) is www.hepalink.com

SHEZF Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen